Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-06-017279
Filing Date
2006-03-16
Accepted
2006-03-16 14:57:51
Documents
6
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) a06-6436_110k.htm 10-K 2137962
2 SUBSIDIARIES OF THE REGISTRANT a06-6436_1ex21d1.htm EX-21.1 1551
3 CONSENTS OF EXPERTS AND COUNSEL a06-6436_1ex23d1.htm EX-23.1 2392
4 302 CERTIFICATION a06-6436_1ex31d1.htm EX-31.1 10280
5 302 CERTIFICATION a06-6436_1ex31d2.htm EX-31.2 10267
6 906 CERTIFICATION a06-6436_1ex32d1.htm EX-32.1 6343
  Complete submission text file 0001104659-06-017279.txt   2170180
Mailing Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008
Business Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19125 | Film No.: 06691502
SIC: 2834 Pharmaceutical Preparations